| # | Title | Journal | Year | Citations |
|---|
| 1 | Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) | Biology of Blood and Marrow Transplantation | 2014 | 141 |
| 2 | Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts | Haematologica | 2013 | 121 |
| 3 | Bloodstream infections caused by Klebsiella pneumoniae in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey | American Journal of Hematology | 2016 | 115 |
| 4 | Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics | MAbs | 2013 | 105 |
| 5 | Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study | Lancet Oncology, The | 2015 | 76 |
| 6 | Primary plasma cell leukemia: a retrospective multicenter study of 73 patients | Annals of Oncology | 2011 | 65 |
| 7 | A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia | Blood | 2020 | 65 |
| 8 | SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients | Infection | 2014 | 59 |
| 9 | Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients | Oncotarget | 2016 | 52 |
| 10 | Invasive Fungal Infections in Patients with Hematologic Malignancies (Aurora Project): Lights and Shadows During 18-Months Surveillance | International Journal of Molecular Sciences | 2012 | 50 |
| 11 | Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia | Journal of Molecular Diagnostics | 2018 | 41 |
| 12 | Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia | Journal of Molecular Diagnostics | 2017 | 34 |
| 13 | Recovery of CMV-Specific CD8+ T Cells and Tregs after Allogeneic Peripheral Blood Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2011 | 31 |
| 14 | The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting | Blood Cancer Journal | 2018 | 30 |
| 15 | Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for “personalized monitoring” of residual disease in chronic myeloid leukemia patients | Oncotarget | 2018 | 29 |
| 16 | SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis | Leukemia | 2018 | 28 |
| 17 | CD3+/Tregs Ratio in Donor Grafts Is Linked to Acute Graft-versus-Host Disease and Immunologic Recovery after Allogeneic Peripheral Blood Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2012 | 27 |
| 18 | Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey | PLoS ONE | 2019 | 27 |
| 19 | In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates | Journal of Medical Microbiology | 2014 | 22 |
| 20 | CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? | Expert Review of Hematology | 2017 | 21 |
| 21 | RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia | Human Pathology | 2018 | 19 |
| 22 | Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation by Donor Graft CD3+/Tregs Ratio: A Single-Center Experience | Biology of Blood and Marrow Transplantation | 2013 | 18 |
| 23 | RARG Gene Dysregulation in Acute Myeloid Leukemia | Frontiers in Molecular Biosciences | 2019 | 18 |
| 24 | Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes | Leukemia Research | 2015 | 17 |
| 25 | Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials | Haematologica | 2020 | 17 |
| 26 | Myeloproliferative and lymphoproliferative disorders: State of the art | Hematological Oncology | 2020 | 16 |
| 27 | Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia | Leukemia | 2019 | 15 |
| 28 | The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3 | Annals of the New York Academy of Sciences | 2010 | 14 |
| 29 | Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice | Annals of Hematology | 2020 | 13 |
| 30 | Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement | Acta Oncológica | 2007 | 9 |
| 31 | Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results | Leukemia and Lymphoma | 2009 | 9 |
| 32 | Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study | Blood | 2021 | 9 |
| 33 | Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors | Hematological Oncology | 2021 | 8 |
| 34 | MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) | Oncology Letters | 2016 | 7 |
| 35 | A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene | Leukemia Research | 2012 | 6 |
| 36 | Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma | Clinical Lymphoma, Myeloma and Leukemia | 2018 | 6 |
| 37 | Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia | Clinical Pharmacology and Therapeutics | 2022 | 6 |
| 38 | Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients | European Journal of Haematology | 2022 | 5 |
| 39 | Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement | International Journal of Laboratory Hematology | 2018 | 3 |
| 40 | Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study | Leukemia | 2021 | 3 |
| 41 | BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? | Leukemia and Lymphoma | 2014 | 2 |
| 42 | Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance | Current Oncology | 2022 | 2 |
| 43 | Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation | Leukemia and Lymphoma | 2015 | 1 |
| 44 | Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burden | BMJ Supportive and Palliative Care | 2020 | 1 |
| 45 | Choice of Frontline Tyrosine-Kinase Inhibitor in Very Elderly Patients with Chronic Myeloid Leukemia: A "Campus CML" Study | Blood | 2021 | 1 |
| 46 | Sequential Treatments in Chronic Phase Chronic Myeloid Leukemia (CML) Patients without Optimal Response after Frontline Nilotinib or Dasatinib: An Italian CML Campus Study | Blood | 2020 | 1 |
| 47 | Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy | Frontiers in Oncology | 2021 | 0 |
| 48 | Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations. | Journal of Clinical Oncology | 2019 | 0 |
| 49 | Waldenström Macroglobulinemia in Young Patients Treated in the Modern Era: A Multi-Institutional Italian Study | Blood | 2019 | 0 |
| 50 | Analysis of Early Events during the First Year of Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase - Chronic Myeloid Leukemia: A "Campus CML" Study | Blood | 2021 | 0 |
